S1. Synthesis & Characterization
Reagents were purchased from commercial sources and used without further purification. 1 H, 13 C NMR, HH COSY, CH HSQC spectra were measured on Bruker Avance III 600 NMR spectrometer ( 1 H = 600 MHz) equipped with a PABBO BB-1H Z GRD probe head or measured on JEOL JNM-AL300 spectrometer ( 1 H = 300 MHz). Chemical shifts were reported as in units of parts per million (ppm), and J-values are in Hz. FAB-MS spectra were measured on JEOL JMS-700W. Compound 1 (glibenclamide, TCI G0382) 1 H, 13 C NMR of glibenclamide was measured for the next step NMR characterization. 163.5, 155.6, 150.4, 145.1, 138.1, 131.4, 129.5, 129.2, 127.2, 124.7, 124.3, 114.0, 56.1, 48.0, 40.1, 34.6, 32.2, 24 .9, 24.1 ppm.
S1-1. Synthesis of Azido-glibenclamide

Compound 2
Concentrated H 2 SO 4 (10 mL) was added to concentrated HNO 3 (10 mL) in an ice bath. To the mixture 1 (3.0 g, 6.3 mmol) as a suspension in 1.4-dioxane (4 mL) was slowly added.
After 30 min stirring at 0 C, the mixture was warmed to room temperature and stirred for 1 hour (Caution: Keep the reaction scale and temperature. If not, the overheated reaction mixture will boil vigorously). The reaction mixture was partitioned between water and ethyl acetate. The organic layer was washed with water ( 2), saturated NaHCO 3 ( 2), brine and dried over anhydrous MgSO 4 . The reaction mixture was dissolved in hot ethanol (100 mL) and slowly cooled. The sonication of the mixture resulted in an emulsion-like precipitate. 163.3, 150.3, 148.2, 144.9, 144.4, 138.2, 133.8, 132.8, 129.2, 127.4, 127.2, 125.3, 62.9, 48.0, 34.3, 32.2, 24.9, 24 164.9, 150.4, 145.1, 143.4, 142.2, 138.1, 130.4, 129.1, 127.8, 127.2, 115.2, 114.6, 59.9, 48.0, 34.5, 32.2, 24.9, 24 1, 134.2, 131.3, 129.7, 124.0, 121.4, 119.3, 108.3, 106.9, 79.9, 72.4, 28.6 ppm.
Compound 7
To 6 (20 mg, 0.080 mmol) in 30 mL of THF was added DIPEA (97 μL, 0.56 mmol)
dropwise. To the reaction mixture was added phosgene (300 μL, 0.42 mmol, 15 wt.% in toluene). The solution was stirred for 4 h under nitrogen gas. After removal of unreacted phosgene gas by rotary evaporator, the residual was co-evaporated with CH 2 Cl 2 (10 mL) and THF (10 mL). The evaporated fraction was neutralized in a NaOH bath. To the residual was added a solution of 2,2-dithiodiethanol (48 μL, 0.40 mmol) in CH 2 Cl 2 /THF (v/v, 1:1). The reaction mixture was stirred overnight. The solvent was evaporated off, at which point CH 2 Cl 2 (30 mL) and water (30 mL) were added, and the organic layer was collected. The CH 2 Cl 2 layer was dried over anhydrous MgSO 4 . After removal of the solvents, the crude product was purified over silica gel using hexane/ethyl acetate (1:2, v/v) to yield the desired 7 as a yellow solid (14 mg, 0.033 mmol, yield: 40%). and sodium ascorbate were added to reach the final concentrations of 1 mM for Cu 2+ and 5 mM for sodium ascorbate. After complete addition, the reaction mixture was maintained for 1 h at room temperature, and the mixture was poured into water and extracted with ethyl acetate. The organic phase was separated and dried over MgSO 4. The solvent was removed by rotary evaporation, and product were purified by silica gel column chromatography using dichloromethane/methanol (10:1) 163.8, 163.6, 162.6, 152.9, 149.1, 144.7, 144.0, 134.1, 132.7, 131.3, 131.2, 129.8, 129.7, 129.5, 129.1, 127.5, 127.2, 125.0, 124.0, 121.7, 119.3, 108.2, 107.3, 61.9, 48.0, 34.6, 34.4, 32.2, 30.4, 24.9, 24 9, 163.3, 162.7, 153.9, 150.4, 149.2, 145.0, 143.7, 143.6, 140.9, 138.2, 136.2, 132.8, 131.9, 131.3, 131.1, 129.8, 129.6, 129.3, 128.7, 128.5, 128.0, 127.7, 127.6, 127.3, 126.5, 125.1, 124.2, 124.1, 122.2, 118.6, 117.1, 63.0, 62.0, 59.4, 52.7, 48.0, 41.1, 36.7, 34.4, 32.2, 24.9, 24 
S3. Time Course Measurement in Protein Extracts
Human pancreas carcinoma cell line (MIA PaCa-2) was purchased from American Type Culture Collection (ATCC) (VA. USA). The cells were cultured in DEME (Invitrogen)
supplemented with 10% FCS (Invitrogen). The cells were washed with PBS and subsequently homogenized through sonication in RIPA buffer (20 mM TrisHCl (pH 7.5), 150 mM NaCl, 1 mM Na 2 EDTA, 1 mM EGTA, 1% NP-40, 1% DMSO) with protease inhibitor cocktail for 30 min at 0 C. The homogenate was then centrifuged at 10,000 rpm for 25 min, resulting in a clear supernatant that was transferred into a new tube. After lysis, the protein extracts were quantified by Bradford method.
Each probe was quickly mixed with GSH or protein extracts. The time-course fluorescence was measured by fluorescence plate reader (PerkinElmer VICTORTM 3, excitation filer 450 nm (P450), emission filter BP 510-560 nm (F535)) for 3 h.
The fluorescence intensity at each time point was divided with the fluorescence intensity at 0 min and the relative fluorescence intensity was plotted.
S4. PX-12 Experiment
PX-12 from 0 to 50 M was treated to 1X PBS buffer (pH 7.4) which included 200 g of the MIA PaCa-2 protein extract, and the mixture was incubated for 24 h at 37 C. incubator.
After a day, each probe (5 M) was added and incubated for 10 min (ER-Naph) or 20 min (Mito-Naph). The fluorescence intensity of each sample was measured by following S3.
The fluorescence intensity at each point was normalized with the fluorescence intensity of probe.
